12/2/2021, 3:56 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Novavax

Novavax to start making Omicron-specific vaccines in Jan

Novavax Inc. unveiled on Thursday that it has started on the initial steps required to manufacture an Omicron-specific coronavirus vaccine, with the manufacturing of the vaccine in a commercial facility expected to be ready in January 2022.

The pharmaceutical company also stated that it has started evaluating its existing vaccine against the Omicron variant, with data expected to be available in the next few weeks. Moreover, it said that, so far, its vaccine was effective against all variants of interest and variants of concern.

Pharmaceutical companies are racing to see whether their developed COVID vaccines are effective against the new variant while also striving to develop a new Omicron-specific one. Meanwhile, the new variant is being discovered across the globe, prompting fears of fresh restrictions.

Baha Breaking News (BBN) / OL